Abbott, Mead Johnson and Reckitt

Jury asked to award more than $6 billion in preterm formula case against Abbott, Reckitt's Mead
A lawyer for a Missouri mother on Wednesday asked a jury to make Abbott and Reckitt's Mead Johnson pay a total of more than $6 billion in the latest trial over claims that the companies' formulas for premature babies caused a severe intestinal illness.
Reckitt’s Mead Johnson, Abbott cleared by US court in infant-formula case
The Whitfield family legal case was just one of many still pending relating to the necrotizing enterocolitis (NEC) disease.
Abbott, Mead Johnson Win Defense Verdict Over Preemie Infant Formula
In closing arguments on Wednesday, plaintiff's lawyer Timothy Cronin asked jurors for $6 billion in punitive damages.
Abbott, Reckitt cleared of liability in latest preterm formula case
By Brendan Pierson (Reuters) -Abbott and Reckitt unit Mead Johnson are not responsible for a young boy's debilitating intestinal disease, a jury found on Thursday in a lawsuit accusing them of failing to warn of their premature baby formulas' risks.
Reckitt, Abbott Shares Rise After Baby-Formula Lawsuit Win
Shares in Reckitt Benckiser topped the Stoxx Europe 600 Index after a U.S. court cleared the company of liability in a case concerning its baby formulas.
Abbott Laboratories Shares Rise After Baby-Formula Verdict
A jury found Abbott Laboratories and Mead Johnson, owned by U.K.-based Reckitt Benckiser, not responsible for a young boy's intestinal disease, the result of a lawsuit that alleged the companies failed to warn that its formula for premature infants increased the risk for a bowel disease.
Abbott shares rise after securing first win in premature infant formula trial
Abbott Laboratories shares rose nearly 5% before the bell on Friday, after a jury cleared the company and a Reckitt unit of liability in a lawsuit over their premature baby formulas' risks.
Abbott, Reckitt Unit Defeat Claims in Baby Formula Trial
Abbott Laboratories and a unit of Reckitt Benckiser Group Plc were cleared by a jury over claims they hid risks their premature-infant formulas can cause a bowel disease that severely sickened a baby boy.
Abbott Labs and Reckitt Benckiser shares surge on court’s baby formula ruling
A court in St. Louis, Missouri ruled in favor of Abbott Laboratories and Reckitt Benckiser over claims their specialized baby formula caused users to develop a bowel disease called NEC
Jury sides with Abbott Laboratories in ongoing fight over preterm infant formulas
A St. Louis jury handed Abbott Laboratories a win Thursday, deciding that Abbott, another company and a hospital were not ...
Dairy Reporter4d
Mead Johnson, Abbott Laboratories cleared in NEC trial
The infant formula manufacturers were facing $6.2bn in punitive damages over allegations their infant formula products caused ...
Abbott, Reckitt Stocks Gain as Baby Formula Makers Score Rare Legal Win
The ruling by a Missouri state court jury is a rare legal win for Abbott Laboratories, maker of Similac formula, and Reckitt, ...
EconoTimes5d
Missouri Mother Seeks $6 Billion in Lawsuit Over Premature Baby Formula Risks
Missouri Mother Pursues $6 Billion in Premature Formula Lawsuit Background: A Missouri mother, Elizabeth Whitfield, has filed ...
Mead Johnson Welcomes Defense Verdict in Whitfield Case
Mead Johnson welcomes today’s jury verdict in defendants’ favor in the Whitfield case in Missouri State Court. It demonstrates that the claims in this case were not supported by the science or experts ...
TOP NEWS: Shares in Reckitt Benckiser leap amid Mead Johnson legal win
In response, shares in Reckitt Benckiser soared 9.8% to 5,144.20 pence each in London early Friday. Reckitt was the best performing stock in the FTSE 100 index which was up 0.2%. Abbott Laboratories ...